logo
Plus   Neg
Share
Email

Johnson & Johnson Stock Sinks As U.S. Probes Baby Powder

The U.S. Justice Department is pursuing a criminal probe into whether Johnson & Johnson (JNJ) lied about possible cancer risks of its talcum powder, the Bloomberg reported, citing people with knowledge of the matter.

Shares of J&J declined by 4.15 per cent to close at US$134.30, following the report.

The criminal probe, which hasn't been reported previously, coincides with a regulatory investigation and civil claims by thousands of cancer patients that J&J's Baby Powder talc was responsible for their illness.

J&J disclosed in its annual report in February that it had received subpoenas from the Justice Department and Securities and Exchange Commission related to the ongoing baby powder litigation.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT